HIV Citation List: March 4 - March 18, 2010
Pubmed citations:
1. The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-beta-D-(arabinofuranosyl)uracil phosphoramidate ProTides. Mehellou Y, Balzarini J, McGuigan C. Antivir Chem Chemother. 2010 Mar 9;20(4):153-60.PMID: 20231780
2. Persistent interactions between the biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infection. Thakkar N, Pirrone V, Passic S, Keogan S, Zhu W, Kholodovych V, Welsh W, Rando R, Labib M, Wigdahl B, Krebs FC. Antimicrob Agents Chemother. 2010 Mar 15. [Epub ahead of print]PMID: 20231400
ISI Web of Knowledge citations:
3. Design, synthesis, and biological evaluation of novel substituted [12,3]triazolo[4,5-d]pyrimidines as HIV-1 Tat-TAR interaction inhibitors. Yu, F; Pang, RF; Yuan, DK; He, MZ; Zhang, CL; Chen, SG; Yang, M. PURE AND APPLIED CHEMISTRY, 2010; 82(1): 339-347.
4. A broad-spectrum antiviral targeting entry of enveloped viruses. Wolf, MC; Freiberg, AN; Zhang, TH; Akyol-Ataman, Z; Grock, A; Hong, PW; Li, JR; Watson, NF; Fang, AQ; Aguilar, HC; Porotto, M; Honko, AN; Damoiseaux, R; Miller, JP; Woodson, SE; Chantasirivisal, S; Fontanes, V; Negrete, OA; Krogstad, P; Dasgupta, A; Moscona, A; Hensley, LE; Whelan, SP; Faull, KF; Holbrook, MR; Jung, ME; Lee, B. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010; 107(7): 3157-3162.
5. Design, synthesis, and evaluation of indole compounds as novel inhibitors targeting Gp41. Zhou, GY; Wu, D; Hermel, E; Balogh, E; Gochin, M. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010; 20(5): 1500-1503.
6. N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Mitchell, ML; Son, JC; Guo, HY; Im, YA; Cho, EJ; Wang, JH; Hayes, J; Wang, M; Paul, A; Lansdon, EB; Chen, JM; Graupe, D; Rhodes, G; He, GX; Geleziunas, R; Xu, LH; Kim, CU. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010; 20(5):1589-1592.
7. Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle. Daelemans, D; Dumont, JM; Rosenwirth, B; De Clercq, E; Pannecouque, C. ANTIVIRAL RESEARCH, 2010; 85(2): 418-421.
8. Identification of Novel Human Immunodeficiency Virus Type 1-Inhibitory Peptides Based on the Antimicrobial Peptide Database. Wang, GS; Watson, KM; Peterkofsky, A; Buckheit, RW. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010; 54(3): 1343-1346.